181 related articles for article (PubMed ID: 32959241)
41. Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy.
Pampeno C; Hurtado A; Opp S; Meruelo D
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834397
[TBL] [Abstract][Full Text] [Related]
42. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
[TBL] [Abstract][Full Text] [Related]
43. Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.
Knudsen ML; Ljungberg K; Tatoud R; Weber J; Esteban M; Liljeström P
PLoS One; 2015; 10(2):e0117042. PubMed ID: 25643354
[TBL] [Abstract][Full Text] [Related]
44. Complete sequence of the genomic RNA of O'nyong-nyong virus and its use in the construction of alphavirus phylogenetic trees.
Levinson RS; Strauss JH; Strauss EG
Virology; 1990 Mar; 175(1):110-23. PubMed ID: 2155505
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic and prophylactic applications of alphavirus vectors.
Atkins GJ; Fleeton MN; Sheahan BJ
Expert Rev Mol Med; 2008 Nov; 10():e33. PubMed ID: 19000329
[TBL] [Abstract][Full Text] [Related]
46. Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease.
Sun C; Gardner CL; Watson AM; Ryman KD; Klimstra WB
J Virol; 2014 Feb; 88(4):2035-46. PubMed ID: 24307590
[TBL] [Abstract][Full Text] [Related]
47. Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors.
Vasilakis N; Falvey D; Gangolli SS; Coleman J; Kowalski J; Udem SA; Zamb TJ; Kovacs GR
Nat Biotechnol; 2003 Aug; 21(8):932-5. PubMed ID: 12845329
[TBL] [Abstract][Full Text] [Related]
48. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
[TBL] [Abstract][Full Text] [Related]
49. Alphavirus vectors and vaccination.
Rayner JO; Dryga SA; Kamrud KI
Rev Med Virol; 2002; 12(5):279-96. PubMed ID: 12211042
[TBL] [Abstract][Full Text] [Related]
50. Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19.
Lundstrom K
Viruses; 2020 Nov; 12(11):. PubMed ID: 33218001
[TBL] [Abstract][Full Text] [Related]
51. DNA-launched live-attenuated vaccines for biodefense applications.
Pushko P; Lukashevich IS; Weaver SC; Tretyakova I
Expert Rev Vaccines; 2016 Sep; 15(9):1223-34. PubMed ID: 27055100
[TBL] [Abstract][Full Text] [Related]
52. Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.
Cheng WF; Hung CF; Hsu KF; Chai CY; He L; Polo JM; Slater LA; Ling M; Wu TC
Hum Gene Ther; 2002 Mar; 13(4):553-68. PubMed ID: 11874633
[TBL] [Abstract][Full Text] [Related]
53. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.
Dubensky TW; Driver DA; Polo JM; Belli BA; Latham EM; Ibanez CE; Chada S; Brumm D; Banks TA; Mento SJ; Jolly DJ; Chang SM
J Virol; 1996 Jan; 70(1):508-19. PubMed ID: 8523564
[TBL] [Abstract][Full Text] [Related]
54. DNA Vaccination in Chickens.
Gupta SK; Dey S; Chellappa MM
Methods Mol Biol; 2016; 1404():165-178. PubMed ID: 27076297
[TBL] [Abstract][Full Text] [Related]
55. Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles.
Goldberg SM; Bartido SM; Gardner JP; Guevara-Patiño JA; Montgomery SC; Perales MA; Maughan MF; Dempsey J; Donovan GP; Olson WC; Houghton AN; Wolchok JD
Clin Cancer Res; 2005 Nov; 11(22):8114-21. PubMed ID: 16299244
[TBL] [Abstract][Full Text] [Related]
56. Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle.
Kamrud KI; Alterson K; Custer M; Dudek J; Goodman C; Owens G; Smith JF
J Gen Virol; 2010 Jul; 91(Pt 7):1723-7. PubMed ID: 20181749
[TBL] [Abstract][Full Text] [Related]
57. Live viral vectors: Semliki Forest virus.
Karlsson GB; Liljeström P
Methods Mol Med; 2003; 87():69-82. PubMed ID: 12958450
[No Abstract] [Full Text] [Related]
58. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways.
Leitner WW; Hwang LN; deVeer MJ; Zhou A; Silverman RH; Williams BR; Dubensky TW; Ying H; Restifo NP
Nat Med; 2003 Jan; 9(1):33-9. PubMed ID: 12496961
[TBL] [Abstract][Full Text] [Related]
59. Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy.
Riezebos-Brilman A; de Mare A; Bungener L; Huckriede A; Wilschut J; Daemen T
J Clin Virol; 2006 Mar; 35(3):233-43. PubMed ID: 16448844
[TBL] [Abstract][Full Text] [Related]
60. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
Sun Y; Li HY; Tian DY; Han QY; Zhang X; Li N; Qiu HJ
Vaccine; 2011 Oct; 29(46):8364-72. PubMed ID: 21888938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
